Skip to content
stoqly

Bunge Global

BG NYSE Agricultural Products & Services Financials FY2016–FY2025

Bunge Global's revenue rose 32.4% to $70.3 billion in fiscal 2025. Its net margin was 1.2%, down from 2.1% a year earlier. Free cash flow was −$879 million, against $524 million a year earlier. It paid out $1.0 billion in dividends and buybacks. The diluted share count rose 17.1%.

Last close · Oct 23, 2026

$103.22

0.1%
Value it Compare
Revenue Total sales reported in the income statement.
$70.3B
32.4% vs prior year
Operating margin Operating income as a share of revenue.
—
Net income Profit after all expenses, interest and tax.
$816M
28.2%
Free cash flow Cash from operations minus capital spending.
−$879M
267.7%
Return on capital After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
6.1%
5.2 pts
Market cap Last close times the latest diluted share count, so it is approximate.
$20.2B
Oct 23 close
P/E Last close divided by diluted earnings per share over the last four quarters.
24.1x
On $4.29 EPS (TTM)

About these figures. Years to 2022 come from Bunge Limited, the parent company until Bunge moved its holding company to Switzerland in 2023.

What Bunge Global does

No business description yet.

Legal name
BUNGE GLOBAL SA
Fiscal year ends
December 31, 2025
Latest annual report
—
Accession · CIK
0001628280-26-009842
0001996862

Revenue and margins

Bunge Global had $70.3B of revenue in fiscal 2025, up 32.4% on the year before.

Revenue
Revenue
Margins, % of revenue
Gross Operating Net FCF
Margins, % of revenue
Gross Operating Net FCF

Net income and earnings per share

From fiscal 2016 to 2025, diluted EPS grew −0.2% a year. Loss periods are shown in red.

Net income
Net income
Diluted EPS
Diluted EPS

Returns on capital

After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.

Return on capital, equity and assets (annual)
Return on capital Return on equity Return on assets

Cash flow

Free cash flow was −$879M in fiscal 2025, −1.3% of revenue. Cash from operations minus capital spending.

Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations Capital spending
Cash from operations vs capital spending
Cash from operations Capital spending

Dividends, buybacks and share count

Bunge Global returned $1.0B to shareholders in fiscal 2025. The diluted share count rose 17.1%.

Dividends and buybacks
Dividends Buybacks
Dividends and buybacks
Dividends Buybacks
Diluted shares outstanding (annual)

Value Bunge Global yourself

Change the assumptions and see what they imply per share. These are models, not forecasts or price targets — the answer depends entirely on what you put in.

Discounted cash flow

Value per share

—

Adds net cash of −$12.2B and divides by 166.5M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.

Earnings multiple

Value per share

—

Reference multiples: today 24.1x · peers 18.6x · sector 24.7x.

Balance sheet

Cash, debt and the ratios that show how comfortably Bunge Global can carry it.

Cash vs debt (incl. leases)
Cash Debt
Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments $1.4B$1.2B$2.7B$3.8B$2.0B
Debt incl. finance leases $6.0B$4.7B$4.9B$6.3B$14.2B
Net debt / EBITDA 1.4x1.2x0.6x1.0x5.0x
Debt / equity 0.8x0.5x0.5x0.6x0.9x
Interest coverage 11.6x6.1x6.9x4.2x2.8x
Current ratio 1.8x1.8x2.1x2.2x1.6x
Quick ratio 0.9x0.9x1.2x1.3x0.7x
Total assets $23.8B$24.6B$25.4B$24.9B$44.5B
Total liabilities $16.0B$14.6B$13.6B$14.0B$27.2B
Shareholders' equity $7.7B$9.2B$10.9B$9.9B$15.9B
Net debt (− = net cash) $4.5B$3.4B$2.2B$2.5B$12.2B

Insider trades

Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.

Bought, 12 months

$0.7M

1 insider

Sold, 12 months

$2.7M

2 insiders

Of sales under plans

0%

$0.0M

DateInsiderTradeSharesPriceValueFiling
Aug 4, 2026 Christopher MahoneyDirector Bought 1,500 $107.60 $0.2M Form 4
Jul 31, 2026 Christopher MahoneyDirector Bought 5,000 $105.53 $0.5M Form 4
Feb 11, 2026 Julio GarrosChief Operating Officer Sold 2,831 $119.00 $0.3M Form 4
Nov 21, 2025 Christos DimopoulosExecutive VP, Global Markets Sold 25,300 $94.37 $2.4M Form 4

Piotroski F-score

Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.

TestFY23FY24FY25
Net income is positive ✓ ✓ ✓
Cash from operations is positive ✓ ✓ ✓
Return on assets rose ✓ ✕ ✕
Cash from operations exceeds net income ✓ ✓ ✓
Debt fell relative to assets ✕ ✕ ✕
Current ratio rose ✓ ✓ ✕
Share count didn't rise ✓ ✓ ✕
Gross margin rose ✓ ✕ ✕
Revenue rose relative to assets ✕ ✕ ✓
F-score 7 / 95 / 94 / 9
Accruals ratio −4.3%−3.0%−0.1%
Altman Z'' 5.655.293.27

Similar companies

Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.

CompanyMarket capGrowthOp. marginFCF marginROICP/EF-score
Bunge Global BG $20.2B 32.4% — −1.3% 6.1% 24.1x 4
Archer Daniels Midland ADM $38.9B −6.2% — 5.2% 5.2% 22.0x 5 Compare →
Dole DOLE $1.3B 8.2% 2.4% 0.0% 6.3% — 6 Compare →
Ingredion INGR $6.1B −2.8% 14.1% 7.1% 16.0% 10.4x 8 Compare →
Darling Ingredients DAR $9.0B 7.4% 4.5% 11.1% 3.2% 15.2x 7 Compare →

10 years of figures

US$ millions unless stated. Hover a ratio's name for its definition.

Download CSV
Fiscal yearFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue $42.7B $45.8B $45.7B $41.1B $41.4B $59.2B $67.2B $59.5B $53.1B $70.3B
Gross profit $2.4B $1.8B $2.3B $542M $2.8B $3.4B $3.7B $4.8B $3.4B $3.4B
Research and development $17.0M $20.0M $15.0M $15.0M $24.0M $33.0M $33.0M $35.0M $30.0M $28.0M
Interest expense $234M $263M $339M $339M $265M $243M $403M $516M $471M $628M
Pretax income $996M $230M $456M −$1.2B $1.4B $2.6B $2.1B $3.1B $1.5B $1.1B
Income tax $220M $56.0M $179M $86.0M $248M $398M $388M $714M $336M $288M
Net income $745M $160M $267M −$1.3B $1.1B $2.1B $1.6B $2.2B $1.1B $816M
Diluted EPS $5.01 $0.89 $1.64 −$9.34 $7.71 $13.64 $10.51 $14.87 $7.99 $4.91
Diluted shares 0.15B 0.14B 0.14B 0.14B 0.15B 0.15B 0.15B 0.15B 0.14B 0.17B
Cash flow
Cash from operations $446M −$2.0B −$1.3B −$808M −$3.5B −$2.9B −$5.5B $3.3B $1.9B $844M
Capital expenditure $784M $662M $493M $524M $365M $399M $555M $1.1B $1.4B $1.7B
Free cash flow −$338M −$2.6B −$1.8B −$1.3B −$3.9B −$3.3B −$6.1B $2.2B $524M −$879M
Depreciation and amortization $547M $609M $622M $548M $435M $424M $408M $451M $468M $703M
Stock-based compensation $44.0M $29.0M $46.0M $39.0M $71.0M $61.0M $65.0M $69.0M $65.0M $73.0M
Acquisitions $34.0M $369M $981M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $4.2B
Share buybacks $200M $0.0M $0.0M $0.0M $100M $100M $200M $600M $1.1B $551M
Dividends paid $223M $247M $271M $283M $282M $289M $349M $383M $378M $459M
Dividends and buybacks $423M $247M $271M $283M $382M $389M $549M $983M $1.5B $1.0B
Balance sheet
Cash and short-term investments $934M $814M $551M $713M $698M $1.4B $1.2B $2.7B $3.8B $2.0B
Total debt $4.3B $4.5B $5.4B $5.0B $7.3B $6.0B $4.7B $4.9B $6.2B $14.1B
Finance lease liabilities $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $17.0M $60.0M $87.0M $180M
Current assets $11.1B $10.4B $11.1B $10.2B $16.2B $16.5B $16.8B $16.4B $16.0B $24.4B
Current liabilities $7.7B $6.2B $7.2B $6.6B $11.0B $9.3B $9.6B $7.7B $7.4B $15.1B
Inventory $4.8B $5.1B $5.9B $5.0B $7.2B $8.4B $8.4B $7.1B $6.5B $13.2B
Property and equipment, net $5.1B $5.3B $5.2B $4.1B $3.8B $3.5B $3.6B $4.5B $5.3B $11.7B
Total assets $19.2B $18.9B $19.4B $18.3B $23.7B $23.8B $24.6B $25.4B $24.9B $44.5B
Total liabilities $11.8B $11.5B $13.0B $12.3B $17.5B $16.0B $14.6B $13.6B $14.0B $27.2B
Shareholders' equity $7.1B $7.1B $6.2B $5.9B $6.1B $7.7B $9.2B $10.9B $9.9B $15.9B
Margins
Gross margin 5.7% 3.9% 5.0% 1.3% 6.7% 5.7% 5.5% 8.1% 6.4% 4.9%
EBITDA margin 4.2% 2.4% 3.1% −0.8% 5.1% 5.5% 4.3% 6.8% 4.6% 3.5%
Net margin 1.8% 0.4% 0.6% −3.1% 2.8% 3.5% 2.4% 3.8% 2.1% 1.2%
FCF margin −0.8% −5.8% −3.8% −3.2% −9.4% −5.6% −9.1% 3.7% 1.0% −1.3%
Returns
Return on capital 9.0% 3.4% 4.4% −6.4% 12.0% 18.9% 15.6% 19.9% 11.3% 6.1%
Return on capital employed 11.1% 4.1% 6.4% −7.2% 13.8% 20.7% 16.8% 21.8% 11.4% 7.5%
Return on equity 11.0% 2.2% 4.0% −21.2% 19.1% 30.3% 19.1% 22.4% 11.0% 6.3%
Return on assets 4.0% 0.8% 1.4% −6.8% 5.5% 8.8% 6.7% 9.0% 4.5% 2.4%
Growth
Revenue growth −1.8% 7.3% −0.1% −10.1% 0.6% 42.9% 13.7% −11.4% −10.8% 32.4%
Net income growth −5.8% −78.5% 66.9% −579.4% — 81.5% −22.5% 39.3% −49.3% −28.2%
EPS growth −1.2% −82.2% 84.3% −669.5% — 76.9% −23.0% 41.5% −46.3% −38.6%
FCF growth — — — — — — — — −76.0% −267.8%
Share count change −2.6% −4.7% 0.3% −0.2% 5.8% 1.8% 0.5% −1.5% −5.7% 17.1%
Financial health
Net debt / EBITDA 1.9x 3.3x 3.4x — 3.1x 1.4x 1.2x 0.6x 1.0x 5.0x
Debt / equity 0.6x 0.6x 0.9x 0.8x 1.2x 0.8x 0.5x 0.5x 0.6x 0.9x
Interest coverage 5.3x 1.9x 2.4x −2.6x 6.3x 11.6x 6.1x 6.9x 4.2x 2.8x
Current ratio 1.4x 1.7x 1.5x 1.6x 1.5x 1.8x 1.8x 2.1x 2.2x 1.6x
Quick ratio 0.8x 0.9x 0.7x 0.8x 0.8x 0.9x 0.9x 1.2x 1.3x 0.7x
Capital allocation
Capex / revenue 1.8% 1.5% 1.1% 1.3% 0.9% 0.7% 0.8% 1.9% 2.6% 2.5%
Stock comp / revenue 0.1% 0.1% 0.1% 0.1% 0.2% 0.1% 0.1% 0.1% 0.1% 0.1%
Payouts / FCF — — — — — — — 45.0% 282.1% —
Quality scores
Piotroski F-score 5.0 4.0 4.0 4.0 4.0 5.0 3.0 7.0 5.0 4.0
Altman Z'' 3.6 3.7 3.5 2.7 3.3 4.5 4.7 5.7 5.3 3.3
Accruals ratio 1.6% 11.2% 8.0% −2.5% 22.3% 21.0% 29.6% −4.3% −3.0% −0.1%

Source: SEC EDGAR XBRL filings (CIK 0001996862). Data updated October 9, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.

↑ ↓ to move · ↵ to open